Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Nephron. Physiology|May 8, 2008
A metabonomic and proteomic analysis of changes in IMCD3 cells chronically adapted to hypertonicityJost Klawitter, Christopher J Rivard, Lewis M Brown, et al.The American Journal of Cardiology|July 28, 2004
Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathyDavid Aguilar, Samuel Z Goldhaber, Daniel J Gans, et al.Circulation. Heart Failure|November 2, 2010
Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trialsRavinder K Wali, Malini Iyengar, Gerald J Beck, et al.Journal of the American Society of Nephrology : JASN|May 4, 2007
Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitorsHarm H H Feringa, Stefanos E Karagiannis, Michel Chonchol, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2011
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trialEdmund J Lewis, Julia B Lewis, Tom Greene, et al.Journal of the American Society of Nephrology : JASN|October 29, 2011
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathyDavid K Packham, Rory Wolfe, Anne T Reutens, et al.Journal of the American Society of Nephrology : JASN|October 29, 2011
Pyridorin in type 2 diabetic nephropathyEdmund J Lewis, Tom Greene, Samuel Spitalewiz, et al.Annals of Internal Medicine|April 2, 2003
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathyTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.Journal of the American Society of Nephrology : JASN|June 3, 2005
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy TrialTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.Kidney International. Supplement|October 16, 2004
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuriaNagesh S Anavekar, Daniel J Gans, Tomas Berl, et al.Pageof 6